SAN DIEGO, April 12, 2017 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will showcase the Company's LessRay® software technology at the International Society for Advancement of Spine Surgery's (ISASS) 17th annual conference held April 12-14, 2017 in Boca Raton, Florida.
LessRay is a proprietary image enhancement technology that improves low-quality, low-radiation images to look more like conventional full-dose images without disrupting surgical workflow. The software is designed to be integrated into current surgeon workflow and utilizes an algorithm to drive image registration and enable management of radiation exposure, while maintaining high-quality, intra-operative images on existing C-Arm workflow without loss of visual accuracy.
NuVasive ISASS17 Participation Details
NuVasive will showcase its technologies at NuVasive Booth #400 on the ISASS exhibit floor.
The Company will host an industry lunch workshop featuring Robert Isaacs, M.D. and LessRay on April 12, 2017 from 12:00 p.m. to 1:30 p.m. at Room Royal 7.
Visit here for more details and the schedule of events.
NuVasive, Inc. (NASDAQ: NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes. NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. With $962 million in revenues (2016), NuVasive has an approximate 2,300 person workforce in more than 40 countries around the world. For more information, please visit www.nuvasive.com.
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nuvasive-to-feature-proprietary-radiation-reduction-platform-at-isass-2017-300438555.html
SOURCE NuVasive, Inc.